Josie Bryant
@josiebryant.bsky.social
260 followers
130 following
21 posts
Group Leader at Wellcome Sanger Institute. Using omics to understand chronic lung infections and lung microbiomes in disease
Posts
Media
Videos
Starter Packs
Reposted by Josie Bryant
Reposted by Josie Bryant
Reposted by Josie Bryant
Reposted by Josie Bryant
Reposted by Josie Bryant
John Lees
@bacpop.org
· 16d
Reposted by Josie Bryant
Reposted by Josie Bryant
Hall Lab
@halllab.bsky.social
· Sep 11
Josie Bryant
@josiebryant.bsky.social
· Aug 20
Reposted by Josie Bryant
Kate Baker
@ksbakes.bsky.social
· Jul 31
Reposted by Josie Bryant
Nicola Lorè
@nicolaivan.bsky.social
· Jul 31
Nature
@nature.com
· Jul 31
SuFEx-based antitubercular compound irreversibly inhibits Pks13 - Nature
A preclinical covalent compound, CMX410, contains a aryl fluorosulfate warhead that targets the acyltransferase domain of Mtb Pks13, an essential enzyme in cell-wall biosynthesis, making it a promising candidate for tuberculosis treatment regimens.
go.nature.com
Reposted by Josie Bryant
Reposted by Josie Bryant
Reposted by Josie Bryant
Muzz Haniffa
@mhaniffa.bsky.social
· Jul 7
Group Leaders- Cellular Genomics
Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing science to solve some of humanity’s greatest challenge...
sanger.wd103.myworkdayjobs.com
Reposted by Josie Bryant
Josie Bryant
@josiebryant.bsky.social
· Jun 18